Mase, Kaori
Saito, Chie
Usui, Joichi
Arimura, Yoshihiro
Nitta, Kosaku
Wada, Takashi
Makino, Hirofumi
Muso, Eri
Hirawa, Nobuhito
Kobayashi, Masaki
Yumura, Wako
Fujimoto, Shouichi
Nakagawa, Naoki
Ito, Takafumi
Yuzawa, Yukio
Matsuo, Seiichi
Yamagata, Kunihiro http://orcid.org/0000-0002-7407-0410
Article History
Received: 7 December 2021
Accepted: 5 July 2022
First Online: 30 July 2022
Declarations
:
: Honoraria: TW (Kyowa Kirin Co. Ltd., Mitsubishi Tanabe Pharma Corp.), NH (Takeda Pharmaceutical Co., Ltd.), KY (Chugai, Daiichi-Sankyo, Kyowakirin, Mochida, Tanabe-Mitsubishi, Pfizer, Asteras). Research funding: TW (Shiseido Co., Ltd., Kyowa Kirin Co., Ltd.), YY (Baxter Ltd., Bayer Yakuhin, Ltd., Chugai Pharmaceutical Co., Ltd., Japan Tobacco Inc., Kyowa Kirin Co., Ltd., Ono Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Sanofi Co., Ltd., Sumitomo Dainippon Pharma Co., Ltd., Torii Pharmaceutical Co., Ltd.), KY (Kyowakirin, Pfizer, Teijin-pharma, Daiichi-Sankyo, Dainihon-Sumitomo, Takeda, Tanabe-Mitsubishi, Asteras, Chugai). Subsidies or Donations: TW (Chugai Pharmaceutical Co., Ltd., Kyowa Kirin Co., Ltd., Mitsubishi Tanabe Pharma Corp., MSD K.K., GlaxoSmithKline K.K.).
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee at which the studies were conducted (IRB approval no.: University of Tsukuba Hospital, H18-117) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.